Get started
BHARAT IMMUNOLOGICALS & BIOLOGBHARAT IMMUNOLOGICALS & BIOLOGBHARAT IMMUNOLOGICALS & BIOLOG

BHARAT IMMUNOLOGICALS & BIOLOG

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

BIBCL chart


Full chart

Key stats


Market capitalization
‪959.46 M‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
—
Revenue (FY)
—
Shares float
—
Beta (1Y)
1.03

About BHARAT IMMUNOLOGICALS & BIOLOG


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Dhananjay Kumar Tiwary
Website
bibcol.com
Headquarters
Bulandshahr
Founded
1989
ISIN
INE994B01014
FIGI
BBG000DNBJX4
Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacturing and producing pharmaceutical products such as oral polio vaccines; zinc tablet and diarrhea management kit; and ready to use therapeutic food. It operates through the following business segments: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. The company was founded on March 10, 1989 and is headquartered in Bulandshahr, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BIBCL news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as BIBCL.

Frequently Asked Questions


The current price of BIBCL is 22.95 INR — it has increased by 1.80% in the past 24 hours. Watch BHARAT IMMUNOLOGICALS & BIOLOG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange BHARAT IMMUNOLOGICALS & BIOLOG stocks are traded under the ticker BIBCL.
BIBCL stock has risen by 1.21% compared to the previous week, the month change is a 3.71% rise, over the last year BHARAT IMMUNOLOGICALS & BIOLOG has showed a −23.63% decrease.
BIBCL reached its all-time high on Jun 18, 2021 with the price of 94.50 INR, and its all-time low was 5.41 INR and was reached on Mar 31, 2020. View more price dynamics on BIBCL chart.
See other stocks reaching their highest and lowest prices.
BIBCL stock is 3.17% volatile and has beta coefficient of 1.03. Track BHARAT IMMUNOLOGICALS & BIOLOG stock price on the chart and check out the list of the most volatile stocks — is BHARAT IMMUNOLOGICALS & BIOLOG there?
Today BHARAT IMMUNOLOGICALS & BIOLOG has the market capitalization of ‪976.73 M‬, it has increased by 2.26% over the last week.
Yes, you can track BHARAT IMMUNOLOGICALS & BIOLOG financials in yearly and quarterly reports right on TradingView.
No, BIBCL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIBCL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BHARAT IMMUNOLOGICALS & BIOLOG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BHARAT IMMUNOLOGICALS & BIOLOG technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BHARAT IMMUNOLOGICALS & BIOLOG stock shows the sell signal. See more of BHARAT IMMUNOLOGICALS & BIOLOG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.